标题
Why Inhibition of IL-23 Lacked Efficacy in Ankylosing Spondylitis
作者
关键词
-
出版物
Frontiers in Immunology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-03-19
DOI
10.3389/fimmu.2021.614255
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- IL-17A and TNF Modulate Normal Human Spinal Entheseal Bone and Soft Tissue Mesenchymal Stem Cell Osteogenesis, Adipogenesis, and Stromal Function
- (2021) Tobias Russell et al. Cells
- Interleukin‐23 pathway at the enthesis: The emerging story of enthesitis in spondyloarthropathy
- (2020) Charlie Bridgewood et al. IMMUNOLOGICAL REVIEWS
- The psychological impact of quarantine and how to reduce it: rapid review of the evidence
- (2020) Samantha K Brooks et al. LANCET
- TYK2 inhibition reduces type 3 immunity and modifies disease progression in murine spondyloarthritis
- (2020) Eric Gracey et al. JOURNAL OF CLINICAL INVESTIGATION
- Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial
- (2020) Atul Deodhar et al. LANCET
- Response to: ‘Correspondence to ‘Normal human enthesis harbours conventional CD4+ and CD8+ T cells with regulatory features and inducible IL-17A and TNF expression’’ by Wang and Ma
- (2020) Abdulla Watad et al. ANNALS OF THE RHEUMATIC DISEASES
- Intestinal and enthesis innate immunity in early axial spondyloarthropathy
- (2020) Kassem Sharif et al. RHEUMATOLOGY
- Ustekinumab Fails to Show Efficacy in a Phase III Axial Spondyloarthritis Program: The Importance of Negative Results
- (2019) Philip Mease Arthritis & Rheumatology
- Paradoxical Skin Reactions to Biologics in Patients With Rheumatologic Disorders
- (2019) Simone Garcovich et al. Frontiers in Pharmacology
- Mutual interplay between IL-17–producing γδT cells and microbiota orchestrates oral mucosal homeostasis
- (2019) Anneke Wilharm et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Revisiting the combinatorial potential of cytokine subunits in the IL-12 family
- (2019) Sammy Detry et al. BIOCHEMICAL PHARMACOLOGY
- Identification of myeloid cells in the human enthesis as the main source of local IL-23 production
- (2019) Charlie Bridgewood et al. ANNALS OF THE RHEUMATIC DISEASES
- The IL-23p19/EBI3 heterodimeric cytokine termed IL-39 remains a theoretical cytokine in man
- (2019) Charlie Bridgewood et al. INFLAMMATION RESEARCH
- Evidence that tissue resident human enthesis γδT-cells can produce IL-17A independently of IL-23R transcript expression
- (2019) Richard James Cuthbert et al. ANNALS OF THE RHEUMATIC DISEASES
- Is undifferentiated spondyloarthritis a discrete entity? A debate
- (2018) Atul Deodhar et al. AUTOIMMUNITY REVIEWS
- Nature versus nurture in the spectrum of rheumatic diseases: Classification of spondyloarthritis as autoimmune or autoinflammatory
- (2018) Elena Generali et al. AUTOIMMUNITY REVIEWS
- Spondyloarthritis
- (2018) Charlie Bridgewood et al. CURRENT OPINION IN RHEUMATOLOGY
- Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
- (2018) Mark Fleisher et al. DIGESTIVE DISEASES AND SCIENCES
- Diet Modifies Colonic Microbiota and CD4 + T Cell Repertoire to Induce Flares of Colitis in Mice With Myeloid-cell Expression of Interleukin 23
- (2018) Lili Chen et al. GASTROENTEROLOGY
- The role of gut microbiota and IL-23/IL-17 pathway in ankylosing spondylitis immunopathogenesis: New insights and updates
- (2018) Farhad Babaie et al. IMMUNOLOGY LETTERS
- Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints
- (2018) Marie-Astrid Boutet et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The rationale for Janus kinase inhibitors for the treatment of spondyloarthritis
- (2018) Douglas J Veale et al. RHEUMATOLOGY
- Enthesitis: Much More Than Focal Insertion Point Inflammation
- (2018) Abdulla Watad et al. Current Rheumatology Reports
- Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study
- (2018) Dominique Baeten et al. ANNALS OF THE RHEUMATIC DISEASES
- The SKG model of spondyloarthritis
- (2018) M. Arifur Rahman et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease
- (2018) Sayam Dubash et al. RHEUMATOLOGY
- Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis
- (2018) Atul Deodhar et al. Arthritis & Rheumatology
- Why did IL-23p19 inhibition fail in AS: a tale of tissues, trials or translation?
- (2018) Stefan Siebert et al. ANNALS OF THE RHEUMATIC DISEASES
- The advent of IL-17A blockade in ankylosing spondylitis: secukinumab, ixekizumab and beyond
- (2018) Sayam Dubash et al. Expert Review of Clinical Immunology
- Regression of peripheral subclinical enthesopathy in therapy-naïve patients treated with Ustekinumab for moderate-to-severe chronic plaque psoriasis
- (2018) Laura Savage et al. Arthritis & Rheumatology
- The Early Phases of Ankylosing Spondylitis: Emerging Insights From Clinical and Basic Science
- (2018) Abdulla Watad et al. Frontiers in Immunology
- Genetics and Functional Genomics of Spondyloarthritis
- (2018) Félicie Costantino et al. Frontiers in Immunology
- Ustekinumab for Crohn’s Disease
- (2017) Reena Khanna et al. GASTROENTEROLOGY
- Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease
- (2017) Megan Hohenberger et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Enthesitis: from pathophysiology to treatment
- (2017) Georg Schett et al. Nature Reviews Rheumatology
- Brief Report: Group 3 Innate Lymphoid Cells in Human Enthesis
- (2017) Richard J. Cuthbert et al. Arthritis & Rheumatology
- Innate Immune Activation Can Trigger Experimental Spondyloarthritis in HLA-B27/Huβ2m Transgenic Rats
- (2017) Melissa N. van Tok et al. Frontiers in Immunology
- Key Features of Gamma-Delta T-Cell Subsets in Human Diseases and Their Immunotherapeutic Implications
- (2017) Myriam Lawand et al. Frontiers in Immunology
- A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn’s Disease
- (2016) Stephan R Targan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1/PSUMMIT-2)
- (2016) Arthur Kavanaugh et al. ANNALS OF THE RHEUMATIC DISEASES
- A20 inhibition of STAT1 expression in myeloid cells: a novel endogenous regulatory mechanism preventing development of enthesitis
- (2016) Katelijne De Wilde et al. ANNALS OF THE RHEUMATIC DISEASES
- An update on biomarkers in axial spondyloarthritis
- (2016) Klára Prajzlerová et al. AUTOIMMUNITY REVIEWS
- Inflammatory Bowel Disease Provoked by Etanercept: Report of 443 Possible Cases Combined from an IBD Referral Center and the FDA
- (2016) Aoibhlinn O’Toole et al. DIGESTIVE DISEASES AND SCIENCES
- Efficacy of Subcutaneous Secukinumab in Patients with Active Psoriatic Arthritis Stratified by Prior Tumor Necrosis Factor Inhibitor Use: Results from the Randomized Placebo-controlled FUTURE 2 Study
- (2016) A. Kavanaugh et al. JOURNAL OF RHEUMATOLOGY
- IL-12 protects from psoriasiform skin inflammation
- (2016) Paulina Kulig et al. Nature Communications
- Interleukin-23-Dependent γ/δ T Cells Produce Interleukin-17 and Accumulate in the Enthesis, Aortic Valve, and Ciliary Body in Mice
- (2016) Annika Reinhardt et al. Arthritis & Rheumatology
- Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability
- (2015) Jacob S. Lee et al. IMMUNITY
- The immunogenetics of Behçet's disease: A comprehensive review
- (2015) Masaki Takeuchi et al. JOURNAL OF AUTOIMMUNITY
- Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2015) Iain B McInnes et al. LANCET
- Genetics of ankylosing spondylitis—insights into pathogenesis
- (2015) Matthew A. Brown et al. Nature Reviews Rheumatology
- 'MHC-I-opathy'—unified concept for spondyloarthritis and Behçet disease
- (2015) Dennis McGonagle et al. Nature Reviews Rheumatology
- Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
- (2015) Dominique Baeten et al. NEW ENGLAND JOURNAL OF MEDICINE
- γδT Cells: First Line of Defense and Beyond
- (2014) Yueh-hsiu Chien et al. Annual Review of Immunology
- Interleukin-23 Mediates the Intestinal Response to Microbial β-1,3-Glucan and the Development of Spondyloarthritis Pathology in SKG Mice
- (2014) Helen Benham et al. Arthritis & Rheumatology
- Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial
- (2013) Iain B McInnes et al. ANNALS OF THE RHEUMATIC DISEASES
- Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells
- (2013) Peggy Jacques et al. ANNALS OF THE RHEUMATIC DISEASES
- Brief Report: Magnetic Resonance Imaging Assessment of Axial Psoriatic Arthritis: Extent of Disease Relates to HLA-B27
- (2013) Concepción Castillo-Gallego et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
- (2013) Iain B McInnes et al. LANCET
- Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
- (2013) Dominique Baeten et al. LANCET
- Ustekinumab in the treatment of psoriatic arthritis: latest findings and clinical potential
- (2013) Alice Gottlieb et al. Therapeutic Advances in Musculoskeletal Disease
- Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
- (2012) Wolfgang Hueber et al. GUT
- IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells
- (2012) Jonathan P Sherlock et al. NATURE MEDICINE
- Genetic polymorphisms of IL-23R and IL-17A and novel insights into their associations with inflammatory bowel disease
- (2011) S. W. Kim et al. GUT
- IL-23 Is Critical for Induction of Arthritis, Osteoclast Formation, and Maintenance of Bone Mass
- (2011) I. E. Adamopoulos et al. JOURNAL OF IMMUNOLOGY
- The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans
- (2011) Paola Di Meglio et al. PLoS One
- Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses
- (2011) R. Sarin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Low-strength T-cell activation promotes Th17 responses
- (2010) H. A. Purvis et al. BLOOD
- Effect of ustekinumab on physical function and health-related quality of life in patients with psoriatic arthritis: a randomized, placebo-controlled, phase II trial
- (2010) Arthur Kavanaugh et al. CURRENT MEDICAL RESEARCH AND OPINION
- IL-23/IL-17 axis in IBD
- (2010) Massimiliano Sarra et al. INFLAMMATORY BOWEL DISEASES
- Diverse Genome-wide Association Studies Associate the IL12/IL23 Pathway with Crohn Disease
- (2009) Kai Wang et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Spondylarthritis in HLA-B27/human β2-microglobulin-transgenic rats is not prevented by lack of CD8
- (2009) Joel D. Taurog et al. ARTHRITIS AND RHEUMATISM
- Specific Microbiota Direct the Differentiation of IL-17-Producing T-Helper Cells in the Mucosa of the Small Intestine
- (2008) Ivaylo I. Ivanov et al. Cell Host & Microbe
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started